Asie · Bourse & Finance · SCMP Business

China wants 5 innovative drugs with US$1 billion returns by 2030. Which might they be?

Publié par SCMP Business · Hong Kong il y a 1 h

The increasing global appeal of Chinese firms’ novel therapies has propelled the country’s rise as a biomedical powerhouse, but China has yet to produce a drug to rival all-time…

Lire l'article complet sur SCMP Business Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.scmp.com)

China wants 5 innovative drugs with US$1 billion returns by 2030. Which might they be?

À lire aussi

BP eyes bids under India oil, gas policy

Surviving the funding game: how timing can make or break your startup

CME feeder cattle hit 3-month peak after corn price plunge

When couples love their properties more than each other

หุ้น Moderna พุ่ง ขานรับภาครัฐ-เอกชนสหรัฐจับมือพัฒนาวัคซีนรักษามะเร็ง

Tata Motors raises Iveco takeover offer to €14.40 per share, rules out further increase

China wants 5 innovative drugs with US$1 billion returns by 2030. Which might they be?

Partager

À lire aussi

BP eyes bids under India oil, gas policy

Surviving the funding game: how timing can make or break your startup

CME feeder cattle hit 3-month peak after corn price plunge

When couples love their properties more than each other

หุ้น Moderna พุ่ง ขานรับภาครัฐ-เอกชนสหรัฐจับมือพัฒนาวัคซีนรักษามะเร็ง

Tata Motors raises Iveco takeover offer to €14.40 per share, rules out further increase